{"id":9909,"date":"2021-11-04T15:57:41","date_gmt":"2021-11-04T14:57:41","guid":{"rendered":"https:\/\/tecnologiehosting.it\/?p=9909"},"modified":"2021-11-09T11:15:31","modified_gmt":"2021-11-09T10:15:31","slug":"istituto-gaslini-bio4dreams-erapermed","status":"publish","type":"post","link":"https:\/\/bio4dreams.com\/en\/istituto-gaslini-bio4dreams-erapermed\/","title":{"rendered":"L\u2019Istituto Gaslini e Bio4Dreams si aggiudicano un ERAPerMED"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><em>L\u2019Istituto Gaslini e Bio4Dreams, insieme a un consorzio d\u2019eccellenza, si sono aggiudicati un bando europeo per sviluppare nuove tecniche per decodificare le Malattie Sistemiche Autoinfiammatorie.<\/em><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">L\u2019<strong><a href=\"https:\/\/www.gaslini.org\/\" target=\"_blank\" rel=\"noreferrer noopener\">IRCCS Istituto Giannina Gaslini di Genova<\/a><\/strong>, in veste di capofila di un consorzio composto da diverse eccellenze europee nel campo della ricerca clinica, si \u00e8 aggiudicato l\u2019ERAPerMED dal titolo<em> Multidisciplinary research projects on personalised medicine \u2013 Development of clinical support tools for personalised medicine implementation<\/em>.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Bio4Dreams<\/strong> ha ricoperto un ruolo essenziale durante l\u2019ideazione e la stesura del progetto, e sta supportando l\u2019Istituto Gaslini negli adempimenti previsti per la stipula del contratto con l\u2019ente finanziatore.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Il bando dell\u2019ERAPerMED<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\"><strong><a href=\"https:\/\/erapermed.isciii.es\/\" target=\"_blank\" rel=\"noreferrer noopener\">ERAPerMED<\/a><\/strong> \u00e8 un ERA-NET Cofund, bando <strong>cofinanziato<\/strong> dalla Commissione Europea insieme a 32 partner provenienti da 23 Paesi per sostenere progetti di ricerca e innovazione.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Tra i suoi obiettivi ci sono: la promozione dell\u2019eccellenza, l\u2019allineamento delle strategie nazionali di ricerca e la promozione della competitivit\u00e0 tra i pi\u00f9 importanti player europei nel campo della medicina personalizzata, anche attraverso il coinvolgimento di Paesi non appartenenti all\u2019Unione Europea.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Il progetto di Istituto Gaslini<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">L\u2019ambizioso progetto dell\u2019Istituto Gaslini, selezionato tra 204 progetti presentati alla call, mira allo <strong>sviluppo di strumenti di ricerca innovativi<\/strong>, basati su intelligenza artificiale (IA) e <em>deep learning<\/em>, progettati per <strong>decodificare la complessit\u00e0 del genoma delle Malattie Sistemiche Autoinfiammatorie<\/strong> (SAID) <strong>rare e ultra-rare<\/strong>. L\u2019obiettivo \u00e8 ottimizzare la loro classificazione al fine di consentire al personale medico diagnosi pi\u00f9 accurate, prognosi pi\u00f9 attendibili e nuove terapie personalizzate.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Nel progetto sono coinvolti sia i pi\u00f9 grandi registri e archivi di SAID d\u2019Europa sia Associazioni dedicate ai pazienti affetti da queste malattie, i quali saranno coinvolti nella valutazione di tutti gli aspetti (legali, etici e sociali) che emergeranno.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">La durata del progetto \u00e8 di 36 mesi con un finanziamento di oltre 1,3 mln di euro (1.368.382\u20ac).<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Il consorzio<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Oltre all\u2019Istituto Giannina Gaslini e a Bio4Dreams, il consorzio comprende l\u2019<strong><a href=\"https:\/\/www.iit.it\/it\/\">Istituto Italiano di Tecnologia (IIT)<\/a><\/strong>, il <strong><a href=\"https:\/\/www.uni-muenster.de\/de\/\" target=\"_blank\" rel=\"noreferrer noopener\">Westf\u00e4lische Wilhelms-Universit\u00e4t M\u00fcnster<\/a><\/strong> (WWU, Germania), l\u2019<strong><a href=\"https:\/\/www.ait.ac.at\/\" target=\"_blank\" rel=\"noreferrer noopener\">Austrian Institute Of Technology<\/a><\/strong> (AIT, Austria), la <strong><a href=\"https:\/\/www.clinicbarcelona.org\/idibaps\" target=\"_blank\" rel=\"noreferrer noopener\">Fundaci\u00f3 Cl\u00ednic per a la Recerca Biom\u00e8dica<\/a><\/strong> (FCRB, Spagna) e l\u2019<strong><a href=\"http:\/\/www.tip.hacettepe.edu.tr\/\" target=\"_blank\" rel=\"noreferrer noopener\">Hacettepe \u00dcniversitesi T\u0131p Fak\u00fcltesi<\/a><\/strong> (Turchia).<\/p>\n","protected":false},"excerpt":{"rendered":"<p>L\u2019Istituto Gaslini e Bio4Dreams, insieme a un consorzio d\u2019eccellenza, si sono aggiudicati un bando europeo per sviluppare nuove tecniche per decodificare le Malattie Sistemiche Autonfiammatorie.<\/p>\n","protected":false},"author":2,"featured_media":9912,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"categories":[18],"tags":[],"class_list":["post-9909","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-corporate"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.7 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>L\u2019Istituto Gaslini e Bio4Dreams si aggiudicano un ERAPerMED<\/title>\n<meta name=\"description\" content=\"Istituto Gaslini, Bio4Dreams e il loro consorzio si aggiudicano un bando europeo per sviluppare tecniche per decodificare le Malattie SAID.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/bio4dreams.com\/istituto-gaslini-bio4dreams-erapermed\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"L\u2019Istituto Gaslini e Bio4Dreams si aggiudicano un ERAPerMED\" \/>\n<meta property=\"og:description\" content=\"Istituto Gaslini, Bio4Dreams e il loro consorzio si aggiudicano un bando europeo per sviluppare tecniche per decodificare le Malattie SAID.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/bio4dreams.com\/istituto-gaslini-bio4dreams-erapermed\/\" \/>\n<meta property=\"og:site_name\" content=\"Bio4Dreams\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/Bio4Dreams\/\" \/>\n<meta property=\"article:published_time\" content=\"2021-11-04T14:57:41+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2021-11-09T10:15:31+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/bio4dreams.com\/wp-content\/uploads\/Istituto-Gaslini-Bio4Dreams-ERAPerMED-malattie-SAID.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"630\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Bio4Dreams\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@bio4dreams\" \/>\n<meta name=\"twitter:site\" content=\"@bio4dreams\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Bio4Dreams\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/bio4dreams.com\\\/istituto-gaslini-bio4dreams-erapermed\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/bio4dreams.com\\\/istituto-gaslini-bio4dreams-erapermed\\\/\"},\"author\":{\"name\":\"Bio4Dreams\",\"@id\":\"https:\\\/\\\/bio4dreams.com\\\/#\\\/schema\\\/person\\\/46cd3f9ef1ad642ee3f40a199ff79588\"},\"headline\":\"L\u2019Istituto Gaslini e Bio4Dreams si aggiudicano un ERAPerMED\",\"datePublished\":\"2021-11-04T14:57:41+00:00\",\"dateModified\":\"2021-11-09T10:15:31+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/bio4dreams.com\\\/istituto-gaslini-bio4dreams-erapermed\\\/\"},\"wordCount\":374,\"publisher\":{\"@id\":\"https:\\\/\\\/bio4dreams.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/bio4dreams.com\\\/istituto-gaslini-bio4dreams-erapermed\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/bio4dreams.com\\\/wp-content\\\/uploads\\\/Istituto-Gaslini-Bio4Dreams-ERAPerMED-malattie-SAID.jpg\",\"articleSection\":[\"Corporate\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/bio4dreams.com\\\/istituto-gaslini-bio4dreams-erapermed\\\/\",\"url\":\"https:\\\/\\\/bio4dreams.com\\\/istituto-gaslini-bio4dreams-erapermed\\\/\",\"name\":\"L\u2019Istituto Gaslini e Bio4Dreams si aggiudicano un ERAPerMED\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/bio4dreams.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/bio4dreams.com\\\/istituto-gaslini-bio4dreams-erapermed\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/bio4dreams.com\\\/istituto-gaslini-bio4dreams-erapermed\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/bio4dreams.com\\\/wp-content\\\/uploads\\\/Istituto-Gaslini-Bio4Dreams-ERAPerMED-malattie-SAID.jpg\",\"datePublished\":\"2021-11-04T14:57:41+00:00\",\"dateModified\":\"2021-11-09T10:15:31+00:00\",\"description\":\"Istituto Gaslini, Bio4Dreams e il loro consorzio si aggiudicano un bando europeo per sviluppare tecniche per decodificare le Malattie SAID.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/bio4dreams.com\\\/istituto-gaslini-bio4dreams-erapermed\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/bio4dreams.com\\\/istituto-gaslini-bio4dreams-erapermed\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/bio4dreams.com\\\/istituto-gaslini-bio4dreams-erapermed\\\/#primaryimage\",\"url\":\"https:\\\/\\\/bio4dreams.com\\\/wp-content\\\/uploads\\\/Istituto-Gaslini-Bio4Dreams-ERAPerMED-malattie-SAID.jpg\",\"contentUrl\":\"https:\\\/\\\/bio4dreams.com\\\/wp-content\\\/uploads\\\/Istituto-Gaslini-Bio4Dreams-ERAPerMED-malattie-SAID.jpg\",\"width\":1200,\"height\":630,\"caption\":\"ERAPerMED | malattie SAID\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/bio4dreams.com\\\/istituto-gaslini-bio4dreams-erapermed\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/bio4dreams.com\\\/en\\\/home\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"L\u2019Istituto Gaslini e Bio4Dreams si aggiudicano un ERAPerMED\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/bio4dreams.com\\\/#website\",\"url\":\"https:\\\/\\\/bio4dreams.com\\\/\",\"name\":\"Bio4Dreams\",\"description\":\"La Business Nursery per le Scienze della Vita\",\"publisher\":{\"@id\":\"https:\\\/\\\/bio4dreams.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/bio4dreams.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/bio4dreams.com\\\/#organization\",\"name\":\"Bio4Dreams S.p.A.\",\"url\":\"https:\\\/\\\/bio4dreams.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/bio4dreams.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Bio4Dreams S.p.A.\"},\"image\":{\"@id\":\"https:\\\/\\\/bio4dreams.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/Bio4Dreams\\\/\",\"https:\\\/\\\/x.com\\\/bio4dreams\",\"https:\\\/\\\/www.instagram.com\\\/bio4dreams\\\/\",\"https:\\\/\\\/it.linkedin.com\\\/company\\\/bio4dreams\",\"https:\\\/\\\/www.youtube.com\\\/channel\\\/UClKlMPs6Lgd23ZIHlnCI4QA\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/bio4dreams.com\\\/#\\\/schema\\\/person\\\/46cd3f9ef1ad642ee3f40a199ff79588\",\"name\":\"Bio4Dreams\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b01bebe85fb01519a2f8a5a3197c5ed994c848e6a4b167c2cb0a0cbc77e8bfed?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b01bebe85fb01519a2f8a5a3197c5ed994c848e6a4b167c2cb0a0cbc77e8bfed?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b01bebe85fb01519a2f8a5a3197c5ed994c848e6a4b167c2cb0a0cbc77e8bfed?s=96&d=mm&r=g\",\"caption\":\"Bio4Dreams\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"L\u2019Istituto Gaslini e Bio4Dreams si aggiudicano un ERAPerMED","description":"Istituto Gaslini, Bio4Dreams e il loro consorzio si aggiudicano un bando europeo per sviluppare tecniche per decodificare le Malattie SAID.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/bio4dreams.com\/istituto-gaslini-bio4dreams-erapermed\/","og_locale":"en_US","og_type":"article","og_title":"L\u2019Istituto Gaslini e Bio4Dreams si aggiudicano un ERAPerMED","og_description":"Istituto Gaslini, Bio4Dreams e il loro consorzio si aggiudicano un bando europeo per sviluppare tecniche per decodificare le Malattie SAID.","og_url":"https:\/\/bio4dreams.com\/istituto-gaslini-bio4dreams-erapermed\/","og_site_name":"Bio4Dreams","article_publisher":"https:\/\/www.facebook.com\/Bio4Dreams\/","article_published_time":"2021-11-04T14:57:41+00:00","article_modified_time":"2021-11-09T10:15:31+00:00","og_image":[{"width":1200,"height":630,"url":"https:\/\/bio4dreams.com\/wp-content\/uploads\/Istituto-Gaslini-Bio4Dreams-ERAPerMED-malattie-SAID.jpg","type":"image\/jpeg"}],"author":"Bio4Dreams","twitter_card":"summary_large_image","twitter_creator":"@bio4dreams","twitter_site":"@bio4dreams","twitter_misc":{"Written by":"Bio4Dreams","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/bio4dreams.com\/istituto-gaslini-bio4dreams-erapermed\/#article","isPartOf":{"@id":"https:\/\/bio4dreams.com\/istituto-gaslini-bio4dreams-erapermed\/"},"author":{"name":"Bio4Dreams","@id":"https:\/\/bio4dreams.com\/#\/schema\/person\/46cd3f9ef1ad642ee3f40a199ff79588"},"headline":"L\u2019Istituto Gaslini e Bio4Dreams si aggiudicano un ERAPerMED","datePublished":"2021-11-04T14:57:41+00:00","dateModified":"2021-11-09T10:15:31+00:00","mainEntityOfPage":{"@id":"https:\/\/bio4dreams.com\/istituto-gaslini-bio4dreams-erapermed\/"},"wordCount":374,"publisher":{"@id":"https:\/\/bio4dreams.com\/#organization"},"image":{"@id":"https:\/\/bio4dreams.com\/istituto-gaslini-bio4dreams-erapermed\/#primaryimage"},"thumbnailUrl":"https:\/\/bio4dreams.com\/wp-content\/uploads\/Istituto-Gaslini-Bio4Dreams-ERAPerMED-malattie-SAID.jpg","articleSection":["Corporate"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/bio4dreams.com\/istituto-gaslini-bio4dreams-erapermed\/","url":"https:\/\/bio4dreams.com\/istituto-gaslini-bio4dreams-erapermed\/","name":"L\u2019Istituto Gaslini e Bio4Dreams si aggiudicano un ERAPerMED","isPartOf":{"@id":"https:\/\/bio4dreams.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/bio4dreams.com\/istituto-gaslini-bio4dreams-erapermed\/#primaryimage"},"image":{"@id":"https:\/\/bio4dreams.com\/istituto-gaslini-bio4dreams-erapermed\/#primaryimage"},"thumbnailUrl":"https:\/\/bio4dreams.com\/wp-content\/uploads\/Istituto-Gaslini-Bio4Dreams-ERAPerMED-malattie-SAID.jpg","datePublished":"2021-11-04T14:57:41+00:00","dateModified":"2021-11-09T10:15:31+00:00","description":"Istituto Gaslini, Bio4Dreams e il loro consorzio si aggiudicano un bando europeo per sviluppare tecniche per decodificare le Malattie SAID.","breadcrumb":{"@id":"https:\/\/bio4dreams.com\/istituto-gaslini-bio4dreams-erapermed\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/bio4dreams.com\/istituto-gaslini-bio4dreams-erapermed\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/bio4dreams.com\/istituto-gaslini-bio4dreams-erapermed\/#primaryimage","url":"https:\/\/bio4dreams.com\/wp-content\/uploads\/Istituto-Gaslini-Bio4Dreams-ERAPerMED-malattie-SAID.jpg","contentUrl":"https:\/\/bio4dreams.com\/wp-content\/uploads\/Istituto-Gaslini-Bio4Dreams-ERAPerMED-malattie-SAID.jpg","width":1200,"height":630,"caption":"ERAPerMED | malattie SAID"},{"@type":"BreadcrumbList","@id":"https:\/\/bio4dreams.com\/istituto-gaslini-bio4dreams-erapermed\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/bio4dreams.com\/en\/home\/"},{"@type":"ListItem","position":2,"name":"L\u2019Istituto Gaslini e Bio4Dreams si aggiudicano un ERAPerMED"}]},{"@type":"WebSite","@id":"https:\/\/bio4dreams.com\/#website","url":"https:\/\/bio4dreams.com\/","name":"Bio4Dreams","description":"La Business Nursery per le Scienze della Vita","publisher":{"@id":"https:\/\/bio4dreams.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/bio4dreams.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/bio4dreams.com\/#organization","name":"Bio4Dreams S.p.A.","url":"https:\/\/bio4dreams.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/bio4dreams.com\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Bio4Dreams S.p.A."},"image":{"@id":"https:\/\/bio4dreams.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/Bio4Dreams\/","https:\/\/x.com\/bio4dreams","https:\/\/www.instagram.com\/bio4dreams\/","https:\/\/it.linkedin.com\/company\/bio4dreams","https:\/\/www.youtube.com\/channel\/UClKlMPs6Lgd23ZIHlnCI4QA"]},{"@type":"Person","@id":"https:\/\/bio4dreams.com\/#\/schema\/person\/46cd3f9ef1ad642ee3f40a199ff79588","name":"Bio4Dreams","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/b01bebe85fb01519a2f8a5a3197c5ed994c848e6a4b167c2cb0a0cbc77e8bfed?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/b01bebe85fb01519a2f8a5a3197c5ed994c848e6a4b167c2cb0a0cbc77e8bfed?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/b01bebe85fb01519a2f8a5a3197c5ed994c848e6a4b167c2cb0a0cbc77e8bfed?s=96&d=mm&r=g","caption":"Bio4Dreams"}}]}},"_links":{"self":[{"href":"https:\/\/bio4dreams.com\/en\/wp-json\/wp\/v2\/posts\/9909","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bio4dreams.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bio4dreams.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/bio4dreams.com\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/bio4dreams.com\/en\/wp-json\/wp\/v2\/comments?post=9909"}],"version-history":[{"count":3,"href":"https:\/\/bio4dreams.com\/en\/wp-json\/wp\/v2\/posts\/9909\/revisions"}],"predecessor-version":[{"id":9924,"href":"https:\/\/bio4dreams.com\/en\/wp-json\/wp\/v2\/posts\/9909\/revisions\/9924"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/bio4dreams.com\/en\/wp-json\/wp\/v2\/media\/9912"}],"wp:attachment":[{"href":"https:\/\/bio4dreams.com\/en\/wp-json\/wp\/v2\/media?parent=9909"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bio4dreams.com\/en\/wp-json\/wp\/v2\/categories?post=9909"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bio4dreams.com\/en\/wp-json\/wp\/v2\/tags?post=9909"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}